Concepedia

Esther Drent

ED

8

Publications

937

Citations

8

H-Index

2012

Active since

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Queen Mary University of London

University Medical Center Utrecht

Amsterdam University Medical Centers

Xpand Biotechnology (Netherlands)

Esther Drent is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2012–2021

8

Publications

8

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

Esther Drent, Maria Themeli, Renée Poels et al. · Molecular Therapy · 2017 · 285 citations · Full text

, , +9

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Esther Drent, Richard W.J. Groen, Willy A. Noort et al. · Haematologica · 2016 · 196 citations · Full text

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

Esther Drent, Renée Poels, Ruud Ruiter et al. · Clinical Cancer Research · 2019 · 168 citations · Full text

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

Cordula Gründer, Suzanne van Dorp, Samantha Hol et al. · Blood · 2012 · 84 citations · Full text

Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design

Esther Drent, Renée Poels, Manon Mulders et al. · PLoS ONE · 2018 · 72 citations · Full text

, , +15

Rows per page

1–5 of 8